Stock analysts at HC Wainwright issued their Q1 2025 earnings per share (EPS) estimates for Evotec in a research report ...

EU antitrust regulators have asked pharma rivals and customers for feedback in four business areas in light of Novo Holdings' ...

Novo Nordisk, Applied Materials ... Prepared by BlackRock Investments, LLC, member FINRA.

The CNS Summit Digital Innovation Index, developed in conjunction with IDEA Pharma, was revealed at the CNS Summit annual meeting on November 13. The index evaluates and ranks biopharma companies' ...

SAN ANTONIO — Oral semaglutide 25 mg appears to be just as effective in promoting weight loss and other beneficial outcomes ...

1 Day NVO 1.88% DJIA 0.68% S&P 500 -0.03% Health Care/Life Sciences 2.54% The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing ...

Fidelity Diversified International Fund is a broadly diversified international equity strategy that seeks capital growth by ...

Novo Nordisk has asked the FDA to stop compounding pharmacies making cheaper versions of its semaglutide-based therapies for obesity and diabetes, saying the drug is too complex to be made safely ...